Temper Tamer Homeopathic Oral Spray Recalled for Manufacturing Practice Deviations
Siddha Flower Essences is recalling Temper Tamer homeopathic oral spray (Lot S22-26424D) due to manufacturing practice deviations. The product was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II voluntary precautionary recall based on Current Good Manufacturing Practice deviations. No illnesses, injuries, or reported harm are documented in the source, and the hazard is regulatory compliance rather than a specific documented contamination or defect.
Plain-English summary
Siddha Flower Essences, LLC is recalling Temper Tamer, a 1 fl oz. homeopathic oral spray (NDC 69779-020-01), due to Current Good Manufacturing Practice (CGMP) deviations. The affected lot is S22-26424D with an expiration date of September 27, 2027.
The product was distributed nationwide in the United States.
This is a voluntary recall initiated by the manufacturer. The FDA classified this as a Class II recall.
The recalled product
- Product
- temper tamer, 1 US fl oz. (29.6 mL), Homeopathic Oral Spray, Manufactured by: Siddha Flower Essences, Oxnard, CA, 93030 NDC 69779-020-01.
- Manufacturer
- Siddha Flower Essences, LLC.
- Category
- Drug — Homeopathic
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# S22-26424D
- Exp 9/27/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27